2026.05.27
Q&A on Japan’s Conditional Approval Policies for Pharmaceuticals: Key Clarifications for Global Drug Developers
Introduction to Japan’s Conditional Approval Q&A According to the Q&A document issued by Japan’s Minis […]
2025.05.29
Key Amendments to the PMD Act — Strengthening Conditional Approval and Post-Market Safety
Introduction to Legislative ProgressAccording to news (薬機法等改正法案 参院厚労委で賛成多数で可決 15項目の附帯決議採択 14日にも成立へ | ニュース | ミク […]